Riskpilot← Back to searchSign inGet full accessCOCHLEA AS
ASActiveOrg 888413332Knud Askers Vei 42, 1383 AskerGeneral medical practice activities · NACE 8621Est. 20051 employees
Revenue 2024
NOK 8,2M
-1% vs 2023
EBITDA margin
54.7%
+6% vs 2023
Equity ratio
92.6%
Financial strength
Net profit 2024
NOK 5,1M
+33% vs 2023
| Revenue | NOK 8,2M | -1% |
| EBITDA | NOK 4,5M | +6% |
| Net profit | NOK 5,1M | +33% |
| Total assets | NOK 17,2M | +40% |
| Equity | NOK 15,9M | +47% |
| Employees | 1 | — |
Legal name
COCHLEA AS
Org number
888413332
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
4. juli 2005
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene
Company purpose
Tilby allmenne helse- og legetjenester, investering og deltagelse i annen næringsvirksomhet og virksomhet som herunder hører.
Address
Knud Askers Vei 42, 1383 Asker
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 076 | 7 404 | 7 815 | 8 294 | 8 234 |
| Staff expenses | −911 | −987 | −993 | −1 122 | −1 252 |
| EBITDA | 3 853 | 3 619 | 4 400 | 4 253 | 4 502 |
| Depreciation & amort. | −66 | −66 | −1 | −16 | −16 |
| EBIT | 3 787 | 3 553 | 4 399 | 4 237 | 4 486 |
| Net financials | 174 | 724 | −99 | 650 | 1 639 |
| Profit before tax | 3 962 | 4 278 | 4 300 | 4 887 | 6 125 |
| Tax | 854 | 836 | 945 | 1 033 | 1 006 |
| Net profit | 3 107 | 3 441 | 3 355 | 3 854 | 5 119 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 010 | 4 684 | 8 243 | 12 268 | 17 173 |
| Equity | 7 935 | 3 577 | 6 931 | 10 786 | 15 905 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 075 | 1 107 | 1 311 | 1 482 | 1 268 |
| Total debt | 1 075 | 1 107 | 1 311 | 1 482 | 1 268 |
EBITDA margin
54.7%
This company
15.8%
Market median
+246% vs market
20202024
Equity ratio
92.6%
This company
38.2%
Market median
+142% vs market
20202024
Return on equity
32.2%
This company
18.4%
Market median
+75% vs market
20202024
Net profit margin
62.2%
This company
8.1%
Market median
+668% vs market
20202024
Asset turnover
0.48×
This company
1.12×
Market median
-57% vs market
20202024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AK Deputy Member | Deputy Member | 2005 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2005 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of COCHLEA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Kristine Sørensen Mo | Deputy Member | 0 companies |
| Birger Mo | Chairman | 0 companies |